Plöckinger, U., Prasad, V., Ziagaki, A., Tiling, N., & Poellinger, A. (2018). 2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease. Hum Genomics.

Plöckinger, U., V. Prasad, A. Ziagaki, N. Tiling, και A. Poellinger. "2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) May Not Be a Viable Biomarker in Pompe Disease." Hum Genomics 2018.

Plöckinger, U., et al. "2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) May Not Be a Viable Biomarker in Pompe Disease." Hum Genomics 2018.